Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2014, Vol. 19 ›› Issue (1): 101-104.

Previous Articles     Next Articles

Advances in the study of Burkholderia cepacia complex

WANG Yu-ping, LI Xiao-ning, ZHANG Ying-ying   

  1. Department of Clinical Laboratory, Yijishan Hospital of Wannan Medical College, Wuhu 241001,Anhui, China
  • Received:2012-12-27 Revised:2013-07-26 Online:2014-01-27 Published:2014-02-12

Abstract: The Burkholderia cepacia complex(Bcc) is a group of nonfermenter aerobic gram-negative bactetia also an important opportunistic pathogens which easily causes infections in cystic fibrosis patients and chronic granulomatous disease. All of this result in patients asymptomatic carriage, chronic infection or cepacia syndrome. Besides CF and CG, cases infected of Burkholderia cepacia complex are growing because antimicrobial agents abuse, it induces pneumonia, blood poisoning, wound infected, deeping abscess and urinary tract infections. The advances in the study of the Burkholderia cepacia complex in genomovars, epidemiology characteristic identification approach,virulent factor and resistant mechanism are reviewed in this paper.

Key words: Burkholderia cepacia complex , Genomovars, Epidemiology characteristic, Identification approach, Virulent factor, Resistant mechanism

CLC Number: